Anticoagulant treatment of patients with atrial fibrillation in primary health care
| العنوان: | Anticoagulant treatment of patients with atrial fibrillation in primary health care |
|---|---|
| المؤلفون: | H. Kurunmäki, Ohman S, K. Eskola, Irma Virjo, M. Paloneva, A. M. Wallin, M. Viitaniemi, S. Ylinen, Mauri Isokoski, A. Latva-Nevala |
| المصدر: | Scandinavian Journal of Primary Health Care. 17:59-63 |
| بيانات النشر: | Informa UK Limited, 1999. |
| سنة النشر: | 1999 |
| مصطلحات موضوعية: | Adult, Male, medicine.medical_specialty, Adolescent, medicine.drug_class, Primary health care, Total population, Internal medicine, Atrial Fibrillation, Prevalence, medicine, Humans, Major complication, Child, Finland, Aged, Quality of Health Care, Aged, 80 and over, Prothrombin time, medicine.diagnostic_test, business.industry, Anticoagulant, Infant, Newborn, Public Health, Environmental and Occupational Health, Anticoagulants, Infant, Mean age, Atrial fibrillation, Middle Aged, medicine.disease, Cross-Sectional Studies, Anticoagulant therapy, Child, Preschool, Cardiology, Female, Family Practice, business, Follow-Up Studies |
| الوصف: | Objective - To determine the prevalence of anticoagulant (AC) treatment of patients with atrial fibrillation in primary health care. To identify complications in the same patients during 1 year. Design - Cross-sectional study and 1-year follow-up. Setting - Seven health centres with a total population of 164 093. Subjects - Five hundred and twenty-two anticoagulated patients with atrial fibrillation. Results - The age-adjusted prevalence of AC treated patients with atrial fibrillation was 0.30%. Of the 522 patients, 240 were men, mean age 69.6 years; and 282 women, mean age 75.1 years. At the beginning of the study 85% and after 1 year 81% of the latest prothrombin time values were within recommended range. After 1 year 414 out of the 522 patients continued AC treatment. During the 1-year follow-up 62 patients had minor or major complications. Eleven patients (2.1%) had to discontinue AC treatment because of complications. Prothrombin tests were mainly taken at 3-4 week intervals. Conclusion - High qualit... |
| تدمد: | 1502-7724 0281-3432 |
| DOI: | 10.1080/028134399750002926 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::987351e4d6520a155a578eed3972ad9b https://doi.org/10.1080/028134399750002926 |
| Rights: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....987351e4d6520a155a578eed3972ad9b |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15027724 02813432 |
|---|---|
| DOI: | 10.1080/028134399750002926 |